Summer Exam 3 Flashcards
Seven drug classes used for IBD?
Aminosalicylates (ASAa), corticosteroids, antimicrobials, immunosuppresives (azathioprine), Biologic TNF-a, anti-integrins, IgG monoclonal antibody
What is Ustekinumb and whats it used for?
IgG monoclonal antibody
Used in refractory crohns
First line med for low risk patient with mild crohns?
Bidesonide
Aminosalicylate MOA
azo structure reduces absorption in small intestine to reach terminal ileum and colon where bacteria cleave it into 5-ASA
Pharmacokinetics of 5ASA
not a lot of absorption- small amount undergoes acetylation in gut and liver to metabolite thats excreted by kidneys
5ASA MOA
interferes with production of inflammatory cytokines, may inhibit cellular function of natural killer cells, lymphocytes and macrophages
anti-inflammatory
5ASA uses
First line in mild-mod UC
can be used in crohns but not proven
How to treat IBD in proximal colon?
Azo compounds or mesalamine formulations
Treatment of crohns in small bowel (ileus)?
Mesalamine compounds (pentasa, asacol)
Mesalamine compounds
Pentasa-timed release in small intestine
Asacol-pH in distal ileum/proximal colon
Lialda-pH throughout colon
Rowasa/canasa suppositories-rectum and sigmoid colon
Olsalazine AEs
Secretory diarrhea
Mesalamine AEs
N/V, headache, interstitial nephritis in high doses
Sulfasalazine AEs/monitoring
N/V, headache, rash, anemia, hepatotoxicity, thrombocytopenia, orange skin
Folate replacement, CBC, LFTs
Glucocorticoids MOA
Inhibits production of inflammatory cytokines, reduces expression of inflammatory cell adhesion molecules, inhibits gene transcription
Glucocorticoid Use
IBD flare-up treatment; good anti-inflammatory but don’t cause remission
How do we reduce systemic absorption of steroids?
Rectal administration, only 15-30% absorbed and maxed tissue effects
*hydrocortisone! or budesonide (controlled release)
Budesonide PK
Controlled release in distal ileum/colon, rapid first pass hepatic metabolism resulting in low oral availability
Budesonide Uses
Mil-mod active UC or crohns in ileum or ascending colon
Which budesonide has delivery to ascending-descending colon?
Uceris (for UC only)
Treatment of mod-severe IBD
40-60mg pred (no higher!) initially, then taper after response
Budesonide vs prednisone pros/cons
Budesonide less AEs but less ability to achieve remission (but neither should be used for that, ASAs or immunosuppressives!)
Steroid AEs
Hyperglycemia, dyslipidemia, osteoporosis, hypertension, acne, edema, myopathy, psychosis
Purine analogs (immunosuppressants) options
Azathioprine (better option) and 6-mercaptopurine
Purine analog Pharmacokinetics
Azathioprine rapidly converted to 6MP which undergoes biotransformation via xanthine oxidase and thiopurine methyltransferase
Half life <2 hours and no onset for 17 weeks
Purine analog uses
Ulcerative colitis and Crohn’s initial and maintenance treatment, but takes 3-6 months to see results
Allows for steroid dose reduction
Purine analog AEs
Bone marrow depression, hepatic toxicity, risk of lymphoma, crosses placenta
Purine analog drug interactions
Allopurinol-reduces xanthine oxide catabolism of purine analogs>severe leukopenia
Antibiotic use in IBD
Used for septic complications like abscesses
Remission of active crohns
Methotrexate MOA
inhibits dihydrofolate reductase enzyme (need to prescribe with folate), interferes with interleukin actions, stimulate release of adenosine, apoptosis and death of t-lymphocytes
Methotrexate Uses
Induce and maintain remission in Crohn’s, weekly subQ injection
Methotrexate AEs
Bone marrow depression, alopecia, mucositis, peripheral neuropathy, liver damage
TNF MOA
release of proinflammatory cytokines, t-cell activation and proliferation
Anti-TNFs for Crohns
Infliximab, adalimumab, certolizumab, natalizumab, vedolizumab
Crohn’s treatment with Anti-TNFs
mod-severe disease
1/3 of patients lose response due to development of antibodies
Anti-TNF AEs
Infection due to suppression of T-helpers, development of antibodies (prescribe w/ methotrexate), increased risk of lymphoma, delayed serum-sickness
Anti-integrin MOA (natalizumab/vedolizumab)
Prevents binding to vascular adhesion molecules and migration into surrounding tissue
Anti-integrin uses
Refractory crohns
Anti-integrin AEs/monitoring
Risk of opportunistic infection
Monitor brain MRI, mental status, leukoencephalopathy
Vedolizumab vs Natalizumab
Vedolizumab doesn’t cause leukoencephalopathy (selectively blocks in gut not brain)
Used for crohns AND UC
Ustekinumab MOA
Blocks interleukin activity by inhibiting receptors on Tcells, NK cells and antigen presenting cells
Ustekinumab AEs
antibody development, infection, nasopharyngitis, malignancy (SCC), neurotoxicity
What medications cause hyperprolactinemia?
risperidone is MC
phenothiazines, metoclopramide, antihypertensives, SSRIs, cocaine, HIV drugs
(treated with dopamine agonists)
GH deficiency diagnosis
Peak GH serum concentration <10 in 2 hours after treatment with GH
Reduced IGF
No gold standard test
Treat those with short stature
Growth hormone treatments (drugs and MOA)
Somatropin (recombinant GH) and mecasermin (recombinant IGF)
Regulate lipid and carb metabolism and lean body mass, and production of IGF in peripheral tissues
Required for normal growth
Somatropin indications
Short stature (turner, Noonan, prader-willi), failure to thrive, small for gestational age Children and adults Can also be used for short bowel syndrome
Somatropin AEs
Generally well tolerated in adults
Pseudotumor cerebri, slipped capital femoral epiphysis, scoliosis progression, hyperglycemia
Somatropin Interactions
Glucocorticoids may inhibit GH effect
other hormones may close epiphysis too soon compromising height